Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial.
about
Subunit composition and novel localization of K+ channels in spinal cord4-aminopyridine decreases progesterone production by porcine granulosa cellsEfficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial.Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report.Non-surgical management of spinal cord injury.Recent advances in pathophysiology and treatment of spinal cord injury.An overview of pharmacological approaches for management and repair of spinal cord injuries.A Systematic Review of Experimental Strategies Aimed at Improving Motor Function after Acute and Chronic Spinal Cord Injury.Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability.4-aminopyridine toxicity: a case report and review of the literature.Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial.Absorption characteristics of sustained-release 4-aminopyridine (fampridine SR) in patients with chronic spinal cord injury.Single-Dose pharmacokinetics of sustained-release fampridine (Fampridine-SR) in healthy volunteers and adults with renal impairment.Effects of 4-aminopyridine on cardiac repolarization, PR interval, and heart rate in patients with spinal cord injury.Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury.Effects of long-term 4-aminopyridine therapy on glucose tolerance and glucokinetics in patients with spinal cord injury.Suppression of Inflammatory Demyelinaton and Axon Degeneration through Inhibiting Kv3 Channels.
P2860
Q24290543-F7CF470C-1574-4ADB-A033-56E88EC3D9ECQ24797408-01193CC5-B16D-4F84-BEAA-9FCDF49E0476Q33349202-28E4BE7B-AA7F-49DE-AC91-20B4CC15FEC7Q34338454-9E2248E6-6D00-4B9B-8CEF-C107B2AA5829Q34581480-07E8FE3E-1A33-4DD9-9882-52ED789A742EQ35005402-270B0392-7216-4A91-ACA6-293634C23673Q36092501-457F0045-BAD3-4895-ADFE-CFCCC00C2C07Q36654629-1FA690E2-C4E9-4278-BBC9-57A044363619Q37884071-6979A7E4-3886-4853-8B43-CAB4C2AEADABQ38025327-0C8EEE87-91B9-480C-9438-871305B16738Q40484322-06BE3350-68C2-4086-B174-70DB3046ADA2Q41729745-FBD8C742-A464-4278-9579-D946974B9258Q43228739-2C985AEE-2D9F-47AB-A1F2-6B7E4326EE0BQ44316132-CB16E92E-9F39-4A98-BAB8-9B122FF57BDDQ44424378-75597427-F7E6-4C48-9178-C20126C96D5AQ46757076-935D3D1E-7F59-4D15-8266-38C9C54DC5A5Q47117550-904995C2-54CC-4CD4-8BE1-9993034594DF
P2860
Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Safety and efficacy of 4-amino ...... a long-term, controlled trial.
@en
type
label
Safety and efficacy of 4-amino ...... a long-term, controlled trial.
@en
prefLabel
Safety and efficacy of 4-amino ...... a long-term, controlled trial.
@en
P2093
P2860
P1433
P1476
Safety and efficacy of 4-amino ...... a long-term, controlled trial.
@en
P2093
Brunnemann SR
Charter RS
Hernandez JP
P2860
P304
P356
10.1592/PHCO.19.9.713.31540
P407
P577
1999-06-01T00:00:00Z